Sudarshan Pharma Industries standalone net profit rises 35.70% in the March 2026 quarter

Sales rise 23.67% to Rs 199.81 crore

Net profit of Sudarshan Pharma Industries rose 35.70% to Rs 9.54 crore in the quarter ended March 2026 as against Rs 7.03 crore during the previous quarter ended March 2025. Sales rose 23.67% to Rs 199.81 crore in the quarter ended March 2026 as against Rs 161.57 crore during the previous quarter ended March 2025.

For the full year,net profit rose 56.78% to Rs 21.98 crore in the year ended March 2026 as against Rs 14.02 crore during the previous year ended March 2025. Sales rose 32.84% to Rs 667.50 crore in the year ended March 2026 as against Rs 502.49 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	199.81	161.57	24	667.50	502.49	33
OPM %	9.15	9.42	-	7.34	7.47	-
PBDT	14.23	11.69	22	32.08	24.32	32
PBT	13.23	10.93	21	28.67	21.62	33
NP	9.54	7.03	36	21.98	14.02	57

Powered by Capital Market - Live News